Advisors Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-271
Closed -$6.86K 1453
2023
Q2
$6.86K Sell
271
-553
-67% -$13.9K ﹤0.01% 1403
2023
Q1
$21.3K Sell
824
-842
-51% -$22.5K ﹤0.01% 1379
2022
Q4
$39.4K Sell
1,666
-511
-23% -$13.8K ﹤0.01% 1361
2022
Q3
$55K Sell
2,177
-714
-25% -$25K ﹤0.01% 1341
2022
Q2
$96K Sell
2,891
-652
-18% -$27.7K ﹤0.01% 1293
2022
Q1
$256K Sell
3,543
-581
-14% -$41.9K ﹤0.01% 1173
2021
Q4
$379K Buy
4,124
+860
+26% +$103K 0.01% 1082
2021
Q3
$414K Buy
3,264
+138
+4% +$20.1K 0.01% 1069
2021
Q2
$520K Buy
3,126
+1,171
+60% +$190K 0.01% 988
2021
Q1
$355K Buy
1,955
+1,078
+123% +$250K 0.01% 1096
2020
Q4
$175K Buy
877
+551
+169% +$112K ﹤0.01% 1260
2020
Q3
$71.5K Buy
326
+23
+8% +$4.87K ﹤0.01% 1362
2020
Q2
$57.8K Buy
+303
New +$53.1K ﹤0.01% 1379

Other funds holding TDOC

Advisors Asset Management's TDOC Position: Q3 2023 in Review

Advisors Asset Management sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 271 shares — an estimated $6.86K sold.

Advisors Asset Management first reported a position in TDOC in Q2 2020 and held it in 13 quarters. The position peaked at $520K in Q2 2021. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • Advisors Asset Management reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
  • Advisors Asset Management sold 271 Teladoc Health shares in Q3 2023, an estimated $6.86K.
  • Advisors Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 13 quarters.
  • Advisors Asset Management's Teladoc Health position peaked at $520K in Q2 2021.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Advisors Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.